拉米夫定治疗肝硬化合并肝源性糖尿病患者临床护理分析.docVIP

拉米夫定治疗肝硬化合并肝源性糖尿病患者临床护理分析 　　【摘要】 目的 研究并分析拉米夫定治疗肝硬化合并肝源性糖尿病患者的临床护理措施， 以提高临床治疗与护理效果。方法 146例肝硬化合并肝源性糖尿病患者， 随机分为对照组和观察组， 每组73例。对照组患者进行常规治疗与护理， 观察组患者根据其病情状况运用拉米夫定抗病毒治疗并进行护理干预， 对比两组患者的临床治疗与护理效果。结果 对照组患者的临床治疗总有效率82.19%、护理满意度为83.56%， 观察组患者的临床治疗总有效率91.78%、护理满意度为93.15%， 差异具有统计学意义（P0.05）。结论 肝硬化合并肝源性糖尿病患者运用拉米夫定抗病毒治疗配合系统的护理干预措施疗效显著， 值得临床推广。 　　【关键词】 拉米夫定；肝硬化；肝源性糖尿病；临床疗效；护理 　　【Abstract】 Objective To research and analyze clinical nursing measures for liver cirrhosis complicated with hepatogenous diabetes patients treated by lamivudine， in order to improve clinical curative and nursing effect. Methods A total of 146 patients of liver cirrhosis complicated with hepatogenous diabetes were randomly divided into control group and observation group， with 73 cases in each group. The control group received conventional treatment and nursing， and the observation group received antiviral therapy by lamivudine and nursing intervention on the basis of their disease condition. Clinical curative and nursing effects of the two groups were compared. Results The control group had total effective rate as 82.19% and nursing satisfaction degree as 83.56%. The observation group had total effective rate as 91.78% and nursing satisfaction degree as 93.15%. Their difference had statistical significance （P0.05）. Conclusion Implement of lamivudine in antiviral therapy combined with systematic nursing intervention measures provides precise effect in treating liver cirrhosis complicated with hepatogenous diabetes patients. It is worth clinical promoting. 　　【Key words】 Lamivudine； Liver cirrhosis； Hepatogenous diabetes； Clinical effect； Nursing 　　肝硬化是临床中常见的慢性疾病， 导致肝硬化的常见诱因为肝炎后肝硬化、酒精性肝硬化等， 肝炎后肝硬化是临床中最为常见的诱因[1]。肝硬化患者病程后期极易出现各种并发症， 肝硬化合并肝源性糖尿病是临床中最为常见的肝硬化并发症之一。为了进一步分析拉米夫定治疗肝硬化合并肝源性糖尿病患者的临床护理措施， 以提高临床治疗与护理效果， 本院开展本研究， 并作出报告如下。 　　1 资料与方法 　　1. 1 一般资料 本院2008年6月～2012年12月共收治肝硬化合并肝源性糖尿病患者146例， 其中男76例， 女70例， 年龄25～78岁， 平均年龄（45.5±10.8）岁。纳入标准：肝硬化病史早于糖尿病病史；无糖尿病既往病史或家族病史；符合糖尿病临床诊断标准；临床诊断与相关辅助检查符合肝硬化诊断标准；糖尿病病情变化与肝硬化病情变